COVID-19 vaccine weekly safety report (24 March 2022)

TGA

24 March 2022 - To 20 March 2022, the TGA has received 485 reports which have been assessed as likely to be myocarditis from about 37.9 million doses of Comirnaty (Pfizer) and 73 reports which have been assessed as likely to be myocarditis from about 3.9 million doses of Spikevax (Moderna).

No new cases of vaccine related thrombosis with thrombocytopenia syndrome have been reported this year.

Read TGA News

Michael Wonder

Posted by:

Michael Wonder